Boston Scientific is a global developer, manufacturer, and marketer of medical devices for interventional specialties spanning cardiovascular, respiratory, digestive, oncological, neurological, and urological conditions. The company operates two reportable segments — MedSurg and Cardiovascular — and has advanced less-invasive medical solutions for over 45 years, providing alternatives to surgery for physicians and patients worldwide.
Boston Scientific's strategy focuses on strengthening category leadership, expanding into high-growth adjacencies, driving global expansion, and funding growth through operational discipline. The company invests in R&D for next-generation technologies across all divisions, has completed multiple acquisitions to expand core and adjacent businesses, and emphasizes international growth including emerging markets, alongside digital tools for physician education and sales productivity.
US 43% · Non Us 24% · EMEA 11% · Asia Pacific 10% · …
geographic · FY2025 (ended Dec 2025) · share of tagged segment revenue (10-K XBRL, as filed)
